Stockscreener 앱 받기
23.07
1.01%
0.235
전일 마감가:
$22.84
열려 있는:
$22.59
하루 거래량:
124.30K
Relative Volume:
0.36
시가총액:
$1.11B
수익:
$151.91M
순이익/손실:
$-46.03M
주가수익비율:
-22.85
EPS:
-1.01
순현금흐름:
$5.65M
1주 성능:
+6.90%
1개월 성능:
-5.53%
6개월 성능:
-5.99%
1년 성능:
-17.40%
1일 변동 폭
$22.19
$23.14
1주일 범위
$21.71
$23.14
52주 변동 폭
$19.10
$29.62
바이오라이프 솔루션즈 Stock (BLFS) Company Profile
명칭
Biolife Solutions Inc
전화
(425) 401-1400
주소
3303 MONTE VILLA PARKWAY, BOTHELL, WA
Compare BLFS vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BLFS
Biolife Solutions Inc
|
23.05 | 1.10B | 151.91M | -46.03M | 5.65M | -1.01 |
|
ISRG
Intuitive Surgical Inc
|
498.08 | 177.84B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
182.45 | 51.97B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
82.78 | 40.42B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
47.41 | 39.70B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
256.41 | 37.72B | 5.40B | 1.49B | 1.78B | 10.12 |
바이오라이프 솔루션즈 Stock (BLFS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-22 | 재개 | Stephens | Overweight |
| 2024-09-30 | 개시 | H.C. Wainwright | Buy |
| 2024-04-04 | 개시 | Jefferies | Buy |
| 2023-07-11 | 개시 | Craig Hallum | Buy |
| 2022-04-25 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-10-19 | 개시 | B. Riley Securities | Buy |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-05-14 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2021-03-23 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-09-22 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-09-18 | 개시 | Cowen | Outperform |
| 2020-08-11 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2020-07-08 | 재확인 | Maxim Group | Buy |
| 2020-02-24 | 개시 | Lake Street | Buy |
| 2020-02-19 | 개시 | The Benchmark Company | Buy |
| 2020-02-06 | 재개 | B. Riley FBR | Buy |
| 2020-01-08 | 개시 | Stephens | Overweight |
| 2019-11-21 | 개시 | Oppenheimer | Outperform |
| 2019-07-22 | 개시 | H.C. Wainwright | Buy |
| 2017-11-10 | 재확인 | Maxim Group | Buy |
| 2017-09-19 | 재확인 | Maxim Group | Buy |
| 2017-07-05 | 업그레이드 | Janney | Neutral → Buy |
| 2017-03-10 | 재확인 | Maxim Group | Buy |
| 2017-01-19 | 개시 | Maxim Group | Buy |
모두보기
바이오라이프 솔루션즈 주식(BLFS)의 최신 뉴스
Support Test: Should you avoid BioLife Solutions Inc stock right nowM&A Rumor & Comprehensive Market Scan Insights - baoquankhu1.vn
BioLife Solutions to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update on February 26, 2026 - Eastern Progress
BioLife Solutions, Inc. (BLFS): Analyst Consensus Signals 45.95% Potential Upside - DirectorsTalk Interviews
BioLife Solutions to Report Fourth Quarter and Full Year 2025 Fi - GuruFocus
BioLife Solutions to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update on February 26, 2026 - Benzinga
What are analysts’ price targets for BioLife Solutions Inc.July 2025 Big Picture & AI Powered Market Trend Analysis - mfd.ru
How BioLife’s Exclusive Qkine Cytokine Deal Could Rewire the BLFS Cell and Gene Therapy Story - simplywall.st
Is BioLife Solutions Inc. stock overvalued or fairly pricedStock Surge & Accurate Intraday Trade Tips - mfd.ru
BioLife Solutions (BLFS) Receives a Buy from Lake Street - The Globe and Mail
BioLife Solutions (NASDAQ:BLFS) Stock Price Passes Below Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Biolife Solutions signs multi-year supply agreement with Qkine Limited - marketscreener.com
BioLife Solutions, Inc. Signs Multi-Year Supply Agreement with Qkine Limited to Expand Its Product Portfolio into the Rapidly Growing Cytokines Market - marketscreener.com
BioLife Solutions (BLFS) Secures Supply Deal with Qkine for Key CGT Products - GuruFocus
Biolife Solutions Signs Multi-Year Supply Agreement With Qkine Limited - TradingView
BioLife Solutions Signs Multi-Year Supply Agreement with Qkine Limited to Expand its Product Portfolio into the Rapidly Growing Cytokines Market - Barchart.com
Aug Big Picture: What are analysts price targets for BioLife Solutions Inc2025 Biggest Moves & Weekly Return Optimization Plans - baoquankhu1.vn
What’s the fair value of BioLife Solutions Inc. stockBond Market & Stepwise Swing Trade Plans - mfd.ru
Will BioLife Solutions Inc. stock continue upward momentumTrade Risk Assessment & AI Driven Stock Price Forecasts - mfd.ru
Can BioLife Solutions Inc. expand into new marketsGlobal Markets & Trade Opportunity Analysis - mfd.ru
Northland Securities Keeps Their Buy Rating on BioLife Solutions (BLFS) - The Globe and Mail
Energy Moves: Is BioLife Solutions Inc being accumulated by smart moneyIPO Watch & Fast Entry High Yield Tips - baoquankhu1.vn
BioLife Solutions (NASDAQ:BLFS) Stock Price Crosses Below 200 Day Moving AverageTime to Sell? - MarketBeat
Options Flow: Does BioLife Solutions Inc offer margin of safetyMarket Sentiment Summary & Consistent Return Strategy Ideas - baoquankhu1.vn
BioLife Solutions, Inc. (BLFS) Stock Analysis: A 45% Potential Upside Awaits Investors - DirectorsTalk Interviews
Zacks Industry Outlook Highlights Boston Scientific, ResMed, Phibro Animal Health and BioLife Solutions - Yahoo Finance
H.C. Wainwright Maintains Buy rating on BioLife (BLFS) Stock - MSN
Weekly Recap: Whats the profit margin of BioLife Solutions IncJuly 2025 Retail & Fast Gain Stock Trading Tips - baoquankhu1.vn
Price-Driven Insight from (BLFS) for Rule-Based Strategy - Stock Traders Daily
Movement Recap: Should I invest in BioLife Solutions Inc before earningsWeekly Market Outlook & Real-Time Market Sentiment Reports - baoquankhu1.vn
Is BioLife Solutions Inc a cyclical or defensive stockQuarterly Investment Review & AI Driven Stock Movement Reports - baoquankhu1.vn
Buyout Rumor: What is the PEG ratio of BioLife Solutions IncJuly 2025 Rallies & Weekly High Momentum Picks - baoquankhu1.vn
BioLife Solutions Inc (BLFS) Stock Price Down 4.32% on Jan 28 - GuruFocus
BioLife Solutions (NASDAQ:BLFS) Shares Cross Below Two Hundred Day Moving AverageHere's Why - MarketBeat
BioLife Solutions, Inc. (BLFS): Investor Outlook Highlights 30% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews
Bank Watch: How does NewAmsterdam Pharma Company NV Equity Warrant compare to its peersQuarterly Market Review & Daily Growth Stock Tips - baoquankhu1.vn
Is BioLife Solutions (NASDAQ:BLFS) Weighed On By Its Debt Load? - 富途资讯
(BLFS) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
BioLife Solutions, Inc. (BLFS): Investor Outlook With A 32.86% Potential Upside - DirectorsTalk Interviews
Energy Moves: What is the PEG ratio of BioLife Solutions IncTrade Exit Report & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Is Global Indemnity Group LLC stock undervalued right nowEarnings Miss & Daily Market Momentum Tracking - baoquankhu1.vn
Contrasting BioLife Solutions (NASDAQ:BLFS) and Phibro Animal Health (NASDAQ:PAHC) - Defense World
Stronger Q4 Revenue and Leadership Change Might Change The Case For Investing In BioLife Solutions (BLFS) - simplywall.st
Should you avoid BioLife Solutions Inc. stock right now2025 Winners & Losers & Reliable Breakout Stock Forecasts - bollywoodhelpline.com
Aug Patterns: What margin trends mean for BioLife Solutions Inc stockBuy Signal & Daily Oversold Bounce Ideas - Bộ Nội Vụ
BioLife Solutions reports 20% revenue growth in Q4 2025 By Investing.com - Investing.com Nigeria
Rate Hike: Is BioLife Solutions Inc being accumulated by smart moneyJuly 2025 Setups & Long-Term Capital Growth Strategies - baoquankhu1.vn
BioLife Solutions reports 20% revenue growth in Q4 2025 - Investing.com
Biolife Solutions Announces Preliminary Fourth Quarter And Full Year 2025 Unaudited Revenue From Continuing Operations - TradingView
BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2025 Unaudited Revenue from Continuing Operations - PR Newswire
Summit Creek Advisors LLC Makes New Investment in BioLife Solutions, Inc. $BLFS - MarketBeat
BioLife Solutions announces planned retirement of key executive - TipRanks
바이오라이프 솔루션즈 (BLFS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.36%
0.05%
자본화:
|
볼륨(24시간):